Oxidised and native low-density lipoproteins induce the release of von Willebrand factor from human endothelial cells in vitro

British Journal of Biomedical Science

Volumn 60, Issue 3, 2003, Pages 155-160

  Blann, Andrew D ^a,c   Burrows, G ^b   McCollum, C N ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b STEPPING HILL HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Endothelium; Hypercholesterolemia; Oxidised LDL; Von Willebrand factor

Indexed keywords

INDIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VON WILLEBRAND FACTOR;

ARTICLE; ATHEROSCLEROSIS; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROPHOTOGRAPHY; OXIDATION; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOACTIVITY; SUPERNATANT;

EID: 0141675041     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2003.11783693     Document Type: Article

References (34)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Lip GYH, Blann AD. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997; 34: 255-65.
3. Pearson JD. Markers of endothelial perturbation and damage. Br J Rheumatol 1993; 32: 651-2.
4. Blann AD, Davis A, Miller JP, McCollum CN. von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to vascular disease and the risk factors for atherosclerosis. Am J Hematol 1997; 55: 15-23.
5. Davi G, Romano M, Mezzetti A et al. Increased levels of soluble P-selectin in hypercholesterolaemia patients. Circulation 1998; 97: 953-7.
6. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-5.
7. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
8. Blann AD, Miller JP, McCollum CN. von Willebrand factor and soluble E-selectin as predictors of cardiovascular disease progression in hyperlipidaemia. Atherosclerosis 1997; 132: 151-6.
9. Leake DS. Oxidised low-density lipoproteins and atherogenesis. Br Heart J 1993; 69: 476-8.
10. Witztum JL, Steinberg D. Role of oxidised low-density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-92.
11. Hessler JR, Robertson AL, Chisholm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle cells and endothelial cells in culture. Atherosclerosis 1979; 32: 213-9.
12. Liu B, Sidiropoulos A, Zhao B, Dierichs R. Oxidised LDL damages endothelial cell monolayers and promotes thrombocyte adhesion. Am J Hematol 1998; 57: 341-3.
13. Thorne SA, Abbot SE, Winyard PG, Blake DR, Mills PG. Extent of oxidative modification of low-density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart 1996; 75: 11-6.
14. Jaffe EA, Nachmann RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphological and immunological criteria. J Clin Invest 1973; 52: 2745-56.
15. Evensen SA, Galdal KS, Nilsen E. LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis 1983; 49: 23-30.
16. Kosugi K, Morel DW, DiCorletto PE, Chisholm GM. Toxicity of oxidised low-density lipoprotein to fibroblasts is selective for S phase of the cell cycle. J Cell Physiol 1987; 130: 311-20.
17. Li X, Chen JX, Liao DF, Yu L. Probucol inhibits oxidized low-density lipoprotein-induced adhesion of monocytes to endothelial cells by reducing P-selectin synthesis in vitro. Endothelium 1998; 6: 1-8.
18. Morel DW, Hesseler JR, Chisholm GM. Low-density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983; 24: 1070-6.
19. Asakawa T, Matsushita S. Thiobarbituric acid test for detecting lipid peroxides. Lipids 1979; 14: 401-6.
20. Yagi K. Assay for serum lipid peroxides and its clinical significance. In Yagi K, ed. Lipid peroxides in biology and medicine. New York: Academic Press, 1982: 223-42.
21. Steinberg D. The cholesterol controversy is over. Why did it take so long? Circulation 1989; 80: 1070-8.
22. Short PE, Williams CE, Picken AM, Hill FGH. Factor VIII-related antigen: an improved enzyme immunoassay. Med Lab Sci 1982; 39: 351-5.
23. Blann AD, Garner CM. Indium 111 as a label for endothelial cells and fibroblasts used as target cells in cytotoxicity tests. Med Lab Sci 1985; 42: 92-4.
24. Blann AD, Lip GYH. Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells. Blood Coagul Fibrinolysis 2003; 14: 335-40.
25. Penn MS, Chisholm GM. Oxidised lipoprotein, altered cell function and atherosclerosis. Atherosclerosis 1994; 108 (Suppl): S21-9.
26. Kummerow FA, Olinescu RM, Fleischer L, Handler B, Shinkareva SV. The relationship of oxidised lipids to coronary artery stenosis. Atherosclerosis 2000; 149: 181-90.
27. Claise C, Edeas M, Chaouchi N et al. Oxidised LDL-induced apoptosis in HUVEC but not in the endothelial cell line EA-hy 926. Atherosclerosis 1999; 47: 95-104.
28. Vink H, Constantinescu AA, Spaan JAE. Oxidised lipoproteins degrade the endothelial surface layer. Circulation 2000; 101: 1500-2.
29. Okajima K, Abe H, Binder BR. Endothelial cell injury induced by plasmin in vitro. J Lab Clin Med 1995; 126: 377-84.
30. Lizard G, Monier S, Cordelet C et al. Characterisation and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7 beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler Thromb Vasc Biol 1999; 19: 1190-200.
31. Morel DW, DiCorleto PE, Chisholm GM. Endothelial and smooth muscle cells alter low-density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357-64.
32. Zhou Q, Wasowicz E, Handler B, Fleischer L, Kummerow FA. An excess concentration of oxysterols in the plasma is cytotoxic to cultured endothelial cells. Atherosclerosis 2000; 149: 191-7.
33. Pettersen KS, Boberg KM, Stabursvik A, Prydz H. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells. Arterioscler Thromb 1991; 11: 423-8.
34. Stober C, Clarke A, Mulvaney A, Harland J, Neithercul WD. Cholesterol and Lp(a) as risk factors for coronary heart disease. Br J Biomed Sci 1994: 51; 114-8.